What Is a Difference Between Starch and Glycogen?

Uncover the key distinctions between starch and glycogen, essential energy storage compounds. Learn how their structures impact biological function.

Starch and glycogen are both made of glucose molecules linked together, and they serve the same basic purpose: storing energy for later use. The critical difference is who makes them and how they are built. Plants produce starch; animals produce glycogen. That distinction drives a cascade of structural, functional, and metabolic differences. Starch forms dense, compact granules optimized for slow, long-term storage, while glycogen forms highly branched, water-soluble particles designed for rapid energy release. The differences go deeper than a biology textbook summary, touching on everything from evolutionary pressures to human disease.

Two Molecules, Two Branching Strategies

Both starch and glycogen are polysaccharides, meaning they are long chains of glucose units. The glucose units are connected primarily by the same type of chemical bond, and branches sprout from the main chain through a second type of bond. But the frequency and arrangement of those branches is where starch and glycogen diverge sharply.

Starch is actually a mixture of two molecules: amylose and amylopectin. Amylose is mostly linear, forming long helical chains with very few branch points. Amylopectin is branched, but its branches are spaced relatively far apart and organized in a way that allows them to pack into tight, semicrystalline layers within a starch granule. The ratio of amylose to amylopectin varies by plant species but typically falls around 20-30% amylose and 70-80% amylopectin. This crystalline packing is what makes starch granules insoluble in cold water and resistant to rapid digestion.

Glycogen, by contrast, is a single type of molecule with no amylose counterpart. It is extremely highly branched, with branch points occurring roughly every 8 to 12 glucose units compared to every 20 to 25 in amylopectin. All those branches keep glycogen from forming crystals. Instead, glycogen stays dissolved in the watery interior of cells, forming spherical particles that enzymes can attack from many directions at once. In liver tissue, smaller glycogen particles (called β particles) cluster together into larger α particles, and research suggests the binding between those clusters involves proteins rather than simple sugar-to-sugar links.

Why Branching Density Shapes Energy Strategy

The structural differences between starch and glycogen are not arbitrary. They reflect millions of years of adaptation to fundamentally different energy needs. Plants are stationary. They photosynthesize during the day, store the surplus as starch, and then slowly draw on those reserves overnight or during seasons when sunlight is scarce. There is no urgency. A tightly packed, crystalline granule that resists rapid breakdown is an advantage: it holds a large amount of glucose in a small space without dissolving into the cell’s water and disrupting its chemistry.

Animals face the opposite pressure. Muscles need fuel on demand during a sprint, a fight, or a hunt. The brain requires a constant glucose supply. A storage molecule that can release glucose in milliseconds is worth far more than one that packs efficiently. Glycogen’s dense branching provides exactly that: each branch tip is an access point where an enzyme can clip off a glucose unit, so the more branches there are, the faster glucose can be mobilized. A recent analysis of branch density and chain-length distribution across species concluded that plant amylopectin’s sparse branching is optimal for slow energy storage, while glycogen’s high branch density and short chains support the rapid, continuous energy supply that mobile organisms need.

The trade-off is storage capacity. Glycogen holds water, roughly three grams of water for every gram of glycogen. That makes it bulky. If your body tried to store the same amount of energy as glycogen that a potato stores as starch, you would need to carry a dramatically heavier load. This is one reason animals rely on fat for long-term energy storage and use glycogen only as a short-term buffer.

How Starch Evolved from Glycogen

Here is something that surprises many people: starch appears to be a later evolutionary invention derived from glycogen. The ancestors of plants were single-celled organisms that stored glycogen, just as animals and bacteria do today. When an early eukaryote engulfed a photosynthetic cyanobacterium in the event that gave rise to chloroplasts, the resulting organism eventually shifted from glycogen to starch. Researchers have speculated that starch offered at least three advantages: more carbon could be packed into an osmotically inert form, the host cell could better control carbon flow from the new photosynthetic organelle, and the emerging plant lineage could integrate the cyanobacterium’s sugar output more efficiently. In other words, glycogen came first, and starch is the plant kingdom’s specialized upgrade for a sedentary, photosynthetic lifestyle.

Different Factories, Different Raw Materials

Starch and glycogen are built by different enzymes using different sugar donors, which matters because it means the two pathways are regulated by entirely different signals.

In plants, starch synthesis takes place inside chloroplasts (during the day) and amyloplasts (in storage organs like tubers and seeds). The starting material is ADP-glucose, produced by an enzyme called ADP-glucose pyrophosphorylase, or AGPase. AGPase is the rate-limiting step: it controls how fast glucose gets funneled into starch, and its activity is closely tied to crop productivity. What switches AGPase on is a molecule called 3-phosphoglycerate, a direct product of photosynthesis. Inorganic phosphate switches it off. So starch production ramps up when the plant is photosynthesizing heavily and slows down when it is not. The regulation is essentially photosynthesis-driven.

In animals, glycogen synthesis happens in the cell’s cytoplasm, primarily in liver and muscle cells. The sugar donor here is UDP-glucose, not ADP-glucose. The key enzyme is glycogen synthase, which builds the backbone chain of glycogen. Glycogen synthase is regulated by a feedback loop tied to how full the glycogen stores already are: when glycogen levels are high, the enzyme’s affinity for its substrate drops, slowing further production. When stores are depleted, affinity rises, and synthesis speeds up. Exercise triggers this same activation independently of glycogen content, which is part of why muscles refuel so efficiently after a workout.

The upshot: starch synthesis is geared to sunlight and photosynthesis. Glycogen synthesis is geared to blood sugar, insulin, and physical activity. Same end product in a general sense (a glucose polymer), but the control systems could hardly be more different.

How Each One Gets Broken Down

The breakdown pathways mirror the synthesis differences. In plants, starch degradation at the granule surface involves a suite of enzymes. A key step is the action of β-amylase, which clips pairs of glucose units (maltose) off the chain ends. Because amylopectin’s branches create obstacles, debranching enzymes are needed to untangle them so β-amylase can keep working. Research has shown that a debranching enzyme called ISA3 works primarily at the granule surface, and when it is absent, a backup enzyme handles the job in the surrounding fluid. This multi-step process is inherently slower than glycogen breakdown, which again fits the plant’s strategy of gradual energy release.

Glycogen breakdown in animal cells, called glycogenolysis, is simpler and faster. In the cytoplasm, glycogen phosphorylase clips individual glucose units off the branch tips, releasing them in a ready-to-use form. A debranching enzyme clears the branch points so phosphorylase can continue. There is also a separate breakdown pathway inside lysosomes, where an enzyme called acid α-glucosidase digests glycogen that gets swept up by the cell’s recycling machinery. That lysosomal pathway might seem redundant, but when it fails, the consequences are severe, as we will see shortly.

Where They Are Stored and How Much

In plants, starch is stored in two main contexts. Transient starch accumulates in leaf chloroplasts during the day and is broken down overnight to fuel the plant’s metabolism in the dark. Storage starch builds up in seeds, roots, and tubers, where it can persist for months or even years. A potato tuber or a grain of wheat is, in essence, a dense starch depot. The amounts can be enormous relative to the plant’s mass.

In humans, glycogen stores are modest by comparison. Skeletal muscles hold roughly 500 grams of glycogen across the whole body, and the liver stores about 100 grams. That total of around 600 grams represents roughly 2,400 calories of stored energy, enough to fuel a few hours of vigorous exercise or about a day of sedentary life. Muscle glycogen is reserved for local use: your biceps cannot share their glycogen with your brain. Liver glycogen, on the other hand, serves the whole body. The liver breaks down glycogen and releases free glucose into the bloodstream, which is crucial for maintaining blood sugar between meals and during sleep.

The limited size of glycogen stores has practical significance for athletes. During exercise above about 70% of maximum effort, glycogen is the dominant fuel source, and fatigue sets in when the active muscles run out. This is the physiological basis of “hitting the wall” in endurance events. Carbohydrate loading before a race is an attempt to push muscle glycogen levels as high as possible, buying extra minutes before depletion.

Glycogen, Exercise, and Metabolic Health

Beyond fueling exercise, the depletion and refilling of glycogen stores plays an underappreciated role in metabolic health. After a workout, when muscle glycogen is low, incoming carbohydrates from your next meal are preferentially funneled into refilling those stores. Under resting conditions with insulin present, roughly 70-90% of glucose disposal goes to muscle glycogen synthesis. If you rarely exercise and your glycogen stores stay topped off, that carbohydrate-routing pathway gets less use. Excess glucose is more likely to be converted to fat, which over time contributes to fat accumulation in places it does not belong and to insulin resistance. Regular exercise keeps glycogen stores cycling between depleted and replenished, and that cycling itself helps prevent the metabolic dysfunction that leads to type 2 diabetes.

When Glycogen Metabolism Fails

Glycogen storage diseases (GSDs) are a group of inherited conditions in which one of the enzymes involved in making or breaking down glycogen is deficient or absent. The result is abnormal glycogen accumulation, typically in the liver, muscles, or both, though the heart, kidneys, and brain can also be affected depending on which enzyme is involved. There are over a dozen types of GSD, each named for a different enzyme defect.

The most well-known is GSD type I, sometimes called von Gierke disease. It involves a deficiency in the enzyme that converts glucose-6-phosphate to free glucose in the liver, which is the final step needed to release glucose into the bloodstream. Without that step, glycogen and fat accumulate in the liver and kidneys, and patients experience low blood sugar between meals, an enlarged liver, elevated blood lipids, and growth delays. Management revolves around preventing blood sugar from dropping, often through frequent meals and uncooked cornstarch supplements that release glucose slowly.

GSD type II, or Pompe disease, is the condition caused by a failure of that lysosomal backup pathway mentioned earlier. When the lysosomal enzyme acid α-glucosidase does not work, glycogen accumulates inside lysosomes and eventually destroys muscle tissue, including the heart. Enzyme replacement therapy has transformed the outlook for Pompe disease patients, but the condition illustrates how even a seemingly minor secondary pathway can be essential when it fails.

Starch metabolism disorders in humans are far less dramatic because we do not synthesize starch. The closest analog would be digestive enzyme deficiencies, such as pancreatic insufficiency, where the body has trouble breaking down dietary starch. Those are managed with supplemental digestive enzymes and are a very different category of problem from the organ-damaging buildup seen in GSDs.

Glycogen in Bacteria and Other Unexpected Places

Glycogen is not exclusively an animal molecule. Many bacteria make it too, and they use it for purposes that go well beyond simple energy storage. In the bacterium that causes cholera, for instance, glycogen accumulation increases under low-nitrogen conditions, and mutants unable to produce glycogen show reduced environmental persistence and transmission. Wild-type bacteria accumulated roughly 15-fold more glycogen under nitrogen-poor conditions than under nitrogen-rich ones, and a mutant lacking the key synthetic gene accumulated far less. Glycogen, in this context, appears to help bacteria survive harsh environmental conditions between hosts, acting more like a survival reserve than a quick-release fuel source.

Some cyanobacteria and microalgae also stockpile glycogen, and biotechnologists have been exploring ways to boost that production. By manipulating nutrient supply or engineering key metabolic genes, researchers have pushed cyanobacteria to accumulate substantially more glycogen than normal. The goal is to use sunlight and carbon dioxide to produce glucose polymers that can then be converted to biofuels or industrial feedstocks. It is an early-stage field, but it leverages the fact that glycogen synthesis is widespread across life and relatively straightforward to manipulate.

Starch and Glycogen as Industrial Raw Materials

Starch has been an industrial staple for centuries, used in everything from papermaking to textile sizing to biodegradable packaging. Its availability is enormous: every wheat field, corn harvest, and potato crop produces it in bulk. In the food industry, different starches are selected for their specific properties. Waxy corn starch, which is nearly 100% amylopectin, behaves differently from high-amylose corn starch when heated, gelled, or frozen, and food scientists pick the right starch for each application.

Glycogen has historically been harder to source in quantity, but interest in glycogen-like “dendritic glucans” has been growing. These highly branched glucose polymers, whether extracted from natural sources or synthesized enzymatically from starch or sucrose, have surface properties that make them useful as drug-delivery vehicles, adsorbents, tissue-engineering scaffolds, and biosensor components. Their abundant surface hydroxyl groups provide attachment points for chemical modifications, making them a flexible platform for biomedical engineering. The fact that they are made of glucose also makes them biocompatible and biodegradable, which matters for anything implanted in or injected into the body.

The Iodine Test and Other Quick Identifiers

One of the simplest ways to tell starch and glycogen apart in a lab is the iodine test. When you add iodine solution to starch, the amylose component forms a characteristic deep blue-black color because iodine molecules slip inside the amylose helix and become trapped. Amylopectin gives a reddish-purple color, and glycogen gives a reddish-brown color. The difference comes down to chain length and branching: glycogen’s short, highly branched chains cannot trap iodine as effectively as amylose’s long helices, so the color shift is less dramatic. This is a standard classroom demonstration, but it also has practical applications in food science and histology, where staining for glycogen in tissue samples helps diagnose storage diseases.

In tissue sections, a staining method called Periodic Acid-Schiff (PAS) lights up glycogen deposits in a vivid magenta. Pathologists use PAS staining to spot abnormal glycogen accumulation in liver biopsies, muscle samples, and other tissues. Treating the sample with an enzyme that digests glycogen before staining confirms that what you are seeing is actually glycogen and not another carbohydrate. These simple chemical tests remain invaluable even in an era of genetic sequencing and advanced imaging.